epitumomab: Clinical Trials

4 trials of epitumomab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 unknown. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Terminated 1, Unknown 1
Phase 22Terminated 1, Unknown 1

Follow epitumomab: new trials by email Literature Review of epitumomab trials Research Report on epitumomab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer
BTH1704, IMPRIME PGG, Gemcitabine - Pancreatic Cancer
Phase 1TerminatedUniversity of Illinois at Chicago32014-08-012015-05-01
Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer
AS1402, Letrozole - Breast Carcinoma
Phase 2TerminatedAntisoma Research1102008-09-012009-08-10
Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer
monoclonal antibody HuHMFG1 - Breast Cancer
Phase 1CompletedJonsson Comprehensive Cancer Center242004-05-012013-06-26
Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
monoclonal antibody HuHMFG1 - Breast Cancer
Phase 1 / Phase 2UnknownJonsson Comprehensive Cancer Center2003-05-012013-12-04

Conditions studied

Breast Neoplasms (3)  ·  Anophthalmia with pulmonary hypoplasia (1)  ·  Neoplasm Metastasis (1)  ·  Pancreatic Neoplasms (1)  ·  Recurrence (1)

Sponsors

Jonsson Comprehensive Cancer Center (2)  ·  Antisoma Research (1)  ·  University of Illinois at Chicago (1)

Countries

United States (3)  ·  Russia (1)

Top investigators

Mark D. Pegram, MD (2)  ·  Gary Acton, MA MBBS MRCP (1)  ·  Neeta Venepalli, MD (1)  ·  Nuhad K Ibrahim, MD FACP (1)

Results publications

PMID 19811637, PMID 21878535, PMID 40443562